尔康制药：杭州朗德智能科技有限公司为公司控股孙公司

Core Viewpoint - The company Erkang Pharmaceutical has announced its subsidiary, Hangzhou Longde Intelligent Technology Co., Ltd., is focusing on AI applications in the pharmaceutical field, particularly in rehabilitation robots and security [1] Company Summary - Hangzhou Longde Intelligent Technology Co., Ltd. is a controlling subsidiary of Erkang Pharmaceutical, primarily engaged in the research and development of AI application software in the medical field [1] - The company has obtained operating qualifications for second-class medical devices, including medical electronic instruments, physical therapy and rehabilitation equipment, and traditional Chinese medicine instruments [1] - As of the third quarter of 2025, the company has completed the writing of documents for 3 new software copyrights and 2 invention patents, with one invention patent application having received a preliminary examination approval notice [1] Industry Summary - The focus on AI technology applications in the medical field indicates a growing trend towards integrating advanced technology in healthcare, particularly in rehabilitation and security sectors [1] - The ongoing research and development phase suggests that the company is investing heavily in innovation, which may enhance its competitive edge in the medical technology market [1]